R R

What Is Allogeneic Bone Marrow Transplantation?

Allogeneic bone marrow transplantation is a hematopoietic cell transplant that uses blood-forming stem cells collected from the bone marrow of another person. The donor can be a matched sibling, another relative, or an unrelated donor selected through human leukocyte antigen matching. After conditioning treatment, donor marrow cells are infused through a central venous catheter and travel through the bloodstream to the recipient's bone marrow spaces. If engraftment succeeds, the donor cells establish new blood and immune-cell production.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Allogeneic Bone Marrow Transplantation?

Allogeneic bone marrow transplantation is a hematopoietic cell transplant that uses blood-forming stem cells collected from the bone marrow of another person. The donor can be a matched sibling, another relative, or an unrelated donor selected through human leukocyte antigen matching. After conditioning treatment, donor marrow cells are infused through a central venous catheter and travel through the bloodstream to the recipient's bone marrow spaces. If engraftment succeeds, the donor cells establish new blood and immune-cell production.

read more about allogeneic bone marrow transplantation ...

Copy this HTML:

Copy HTML Copied!

Why Is Allogeneic Bone Marrow Transplantation Performed?

The procedure is used for selected blood cancers, marrow-failure disorders, immune deficiencies, and inherited blood or metabolic diseases that can be treated by replacing abnormal blood-forming cells with donor cells. Common oncologic indications include leukemia, myelodysplastic syndromes, and selected lymphomas, although the exact transplant strategy varies by diagnosis. Human leukocyte antigen matching is used to identify a donor whose immune markers are compatible enough to reduce rejection and graft-versus-host disease risk. The transplant can also provide a graft-versus-tumor effect in which donor immune cells attack residual malignant cells.

How Is Allogeneic Bone Marrow Transplantation Performed?

The donor undergoes bone marrow harvest under anesthesia, most commonly through repeated needle aspirations from the posterior pelvic bones. The recipient receives a conditioning regimen with chemotherapy and sometimes radiation therapy to suppress the immune system, treat the underlying disease, and make space for donor cells. On transplant day, the marrow product is infused through a central venous catheter in a process similar to a blood transfusion rather than an operation. The donor stem cells migrate to the marrow and begin engraftment, producing new blood cells over the following weeks.

What Is Recovery Like After Allogeneic Bone Marrow Transplantation?

Recovery begins with a period of very low blood counts while the donor cells establish themselves in the recipient's marrow. Infection prevention, transfusions, nutrition, fluid management, and monitoring for organ toxicity are major priorities before and during engraftment. The transplant team also watches closely for graft-versus-host disease and gives immune-suppressing medication to reduce its risk. Immune recovery continues for many months after blood counts improve, so revaccination, infection precautions, medication monitoring, and long-term transplant follow-up remain necessary.

What Are the Risks and Complications?

Major complications include severe infection, bleeding, graft failure, organ toxicity from conditioning, and graft-versus-host disease. Graft-versus-host disease occurs when donor immune cells recognize recipient tissues as foreign and can damage the skin, liver, gastrointestinal tract, lungs, or other organs. Immunosuppressive treatment used to prevent or control this complication can further increase infection and metabolic risks. Relapse of the original disease, infertility, secondary cancers, and chronic organ problems are also possible long-term complications.

Frequently Asked Questions About Allogeneic Bone Marrow Transplantation

Where does donor bone marrow come from?

Bone marrow is usually harvested from the donor's posterior pelvic bones under anesthesia using hollow needles designed to collect marrow containing blood-forming stem cells.

Is allogeneic bone marrow transplantation surgery for the recipient?

No. The recipient receives the donor marrow through a central venous catheter in a process similar to a blood transfusion after completing conditioning treatment.

What is graft-versus-host disease?

Graft-versus-host disease occurs when donor immune cells attack the recipient's tissues. It can be acute or chronic and can affect several organs.

How is an allogeneic donor selected?

Human leukocyte antigen matching is central to donor selection, along with donor health, age, availability, disease factors, and other transplant-specific considerations.

References

Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR. PubMed. https://pubmed.ncbi.nlm.nih.gov/40619101/. Date Accessed September 11, 2026.

Bone Marrow Donation Overview & Process. NMDP. https://www.nmdp.org/get-involved/join-the-registry/donate-bone-marrow. Date Accessed September 11, 2026.

Donor Selection for Allogeneic Hematopoietic Cell Transplantation. PubMed. https://pubmed.ncbi.nlm.nih.gov/36949660/. Date Accessed September 11, 2026.

Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy. PubMed. https://pubmed.ncbi.nlm.nih.gov/42060959/. Date Accessed September 11, 2026.

Stem Cell and Bone Marrow Transplants for Cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant. Date Accessed September 11, 2026.